Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1996 1
1997 1
2001 1
2002 2
2003 1
2004 1
2005 4
2006 1
2007 3
2008 8
2009 7
2010 6
2011 9
2012 5
2013 10
2014 14
2015 15
2016 17
2017 20
2018 17
2019 13
2020 15
2021 22
2022 19
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Gay F, Musto P, Rota-Scalabrini D, Bertamini L, Belotti A, Galli M, Offidani M, Zamagni E, Ledda A, Grasso M, Ballanti S, Spadano A, Cea M, Patriarca F, D'Agostino M, Capra A, Giuliani N, de Fabritiis P, Aquino S, Palmas A, Gamberi B, Zambello R, Petrucci MT, Corradini P, Cavo M, Boccadoro M. Gay F, et al. Lancet Oncol. 2021 Dec;22(12):1705-1720. doi: 10.1016/S1470-2045(21)00535-0. Epub 2021 Nov 11. Lancet Oncol. 2021. PMID: 34774221 Free article. Clinical Trial.
The primary endpoints were the proportion of patients with at least a very good partial response after induction with KRd versus KCd and progression-free survival with carfilzomib plus lenalidomide versus lenalidomide alone as maintenance treatment, both assessed in the in …
The primary endpoints were the proportion of patients with at least a very good partial response after induction with KRd versus KCd …
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, Boni L, Unger JM, Anderson RA, Mehta K, Minton S, Poggio F, Albain KS, Adamson DJA, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge AH, Del Mastro L. Lambertini M, et al. J Clin Oncol. 2018 Jul 1;36(19):1981-1990. doi: 10.1200/JCO.2018.78.0858. Epub 2018 May 2. J Clin Oncol. 2018. PMID: 29718793 Free PMC article.

POI rate was 14.1% in the GnRHa group and 30.9% in the control group (adjusted odds ratio, 0.38; 95% CI, 0.26 to 0.57; P < .001). A total of 37 (10.3%) patients had at least one post-treatment pregnancy in the GnRHa group and 20 (5.5%) in the control group (incidence ra

…

POI rate was 14.1% in the GnRHa group and 30.9% in the control group (adjusted odds ratio, 0.38; 95% CI, 0.26 to 0.57; P < .001). A total

…
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F. Platzbecker U, et al. J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 27400939 Free article. Clinical Trial.
Purpose The initial results of the APL0406 trial showed that the combination of all- trans-retinoic acid (ATRA) and arsenic trioxide (ATO) is at least not inferior to standard ATRA and chemotherapy (CHT) in first-line therapy of low- or intermediate-risk acute promyelocyti …
Purpose The initial results of the APL0406 trial showed that the combination of all- trans-retinoic acid (ATRA) and arsenic trioxide (ATO) i …
Indoor poisoning of companion animals by chemicals.
Bertero A, Fossati P, Caloni F. Bertero A, et al. Sci Total Environ. 2020 Sep 1;733:139366. doi: 10.1016/j.scitotenv.2020.139366. Epub 2020 May 15. Sci Total Environ. 2020. PMID: 32446086 Review.
Among them, insecticides (in particular anticholinesterase compounds) and anticoagulant rodenticides are frequently implicated, but molluscicides (i.e. metaldehyde) together with household products have also shown a growing or at least stable trend in the poisoning episode …
Among them, insecticides (in particular anticholinesterase compounds) and anticoagulant rodenticides are frequently implicated, but mollusci …
Chromosomal abnormalities in sperm.
Vidal F, Blanco J, Egozcue J. Vidal F, et al. Mol Cell Endocrinol. 2001 Oct 22;183 Suppl 1:S51-4. doi: 10.1016/s0303-7207(01)00579-2. Mol Cell Endocrinol. 2001. PMID: 11576733 Review.
Studies in control populations have been used to set up the basal level of aneuploidy for all human chromosomes and, based on conservative estimates, the percentage of chromosomally abnormal sperm in the general population could be considered to be at least 6.7%. In carrie …
Studies in control populations have been used to set up the basal level of aneuploidy for all human chromosomes and, based on conservative e …
Human bocavirus: Current knowledge and future challenges.
Guido M, Tumolo MR, Verri T, Romano A, Serio F, De Giorgi M, De Donno A, Bagordo F, Zizza A. Guido M, et al. World J Gastroenterol. 2016 Oct 21;22(39):8684-8697. doi: 10.3748/wjg.v22.i39.8684. World J Gastroenterol. 2016. PMID: 27818586 Free PMC article. Review.
HBoV pathogenicity remains to be fully clarified mainly due to the lack of animal models for the difficulties in replicating the virus in in vitro cell cultures, and the fact that HBoV infection is frequently accompanied by at least another viral and/or bacterial respirato …
HBoV pathogenicity remains to be fully clarified mainly due to the lack of animal models for the difficulties in replicating the virus in in …
Blockchain in radiology research and clinical practice: current trends and future directions.
Tagliafico AS, Campi C, Bianca B, Bortolotto C, Buccicardi D, Francesca C, Prost R, Rengo M, Faggioni L. Tagliafico AS, et al. Radiol Med. 2022 Apr;127(4):391-397. doi: 10.1007/s11547-022-01460-1. Epub 2022 Feb 23. Radiol Med. 2022. PMID: 35194720 Free PMC article. Review.
Only a few research applications have been tested, however, blockchain technology is widely known outside healthcare and widely adopted, especially in Finance, since 2009 at least. Learning by history, radiology is a potential ideal scenario to apply this technology. ...
Only a few research applications have been tested, however, blockchain technology is widely known outside healthcare and widely adopted, esp …
IMMUNOREACT 0: Biopsy-based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer-A systematic review and meta-analysis.
Stepanyan A, Fassan M, Spolverato G, Castagliuolo I, Scarpa M, Scarpa M; IMMUNOREACT Study Group. Stepanyan A, et al. Cancer Med. 2023 Sep;12(17):17878-17890. doi: 10.1002/cam4.6423. Epub 2023 Aug 3. Cancer Med. 2023. PMID: 37537787 Free PMC article. Review.
Studies on patients with rectal cancer undergoing NT in which the predictive significance of at least one of the immunological markers of interest was assessed by immunohistochemistry (IHC) in pretreatment biopsies were included. ...
Studies on patients with rectal cancer undergoing NT in which the predictive significance of at least one of the immunological marker …
Alport syndrome and pregnancy: a case series and literature review.
Brunini F, Zaina B, Gianfreda D, Ossola W, Giani M, Fedele L, Messa P, Moroni G. Brunini F, et al. Arch Gynecol Obstet. 2018 Jun;297(6):1421-1431. doi: 10.1007/s00404-018-4720-x. Epub 2018 Feb 28. Arch Gynecol Obstet. 2018. PMID: 29492669 Review.
Seven pregnancies of six women were monitored by a multidisciplinary team of nephrologists and gynecologists. After delivery, patients were followed for at least 3 years. We compare our results with those in the literature. ...
Seven pregnancies of six women were monitored by a multidisciplinary team of nephrologists and gynecologists. After delivery, patients were …
Smoking in schizophrenic patients: A critique of the self-medication hypothesis.
Manzella F, Maloney SE, Taylor GT. Manzella F, et al. World J Psychiatry. 2015 Mar 22;5(1):35-46. doi: 10.5498/wjp.v5.i1.35. World J Psychiatry. 2015. PMID: 25815253 Free PMC article. Review.
Roots of the self-medication concept in psychiatry date back at least to the 1980s. Observations that rates of smokers in schizophrenic patients are multiple times the rates for regular smoking in the general population, as well as those with other disorders, proved partic …
Roots of the self-medication concept in psychiatry date back at least to the 1980s. Observations that rates of smokers in schizophren …
209 results